EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹259 Cr | ₹394 Cr | ₹286 Cr | ₹97 Cr | ₹12 Cr |
What is the latest Contingent Liabilities ratio of EMCURE PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹259 Cr |
| Mar2025 | ₹394 Cr |
| Mar2024 | ₹286 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹12 Cr |
How is Contingent Liabilities of EMCURE PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹259 Cr | -34.27 | |
| Mar2025 | ₹394 Cr | 37.98 | |
| Mar2024 | ₹286 Cr | 194.49 | |
| Mar2023 | ₹97 Cr | 703.28 | |
| Mar2022 | ₹12 Cr | - | |
Compare Contingent Liabilities of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹44,314.9 Cr | -0.1% | 30.9% | 68.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹452,299.0 Cr | 1% | 7.5% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹297,325.0 Cr | 0.8% | 22.8% | 71.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹178,727.0 Cr | 0.2% | 1.9% | 20.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,145.0 Cr | 0.8% | 12.2% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,312.0 Cr | 1.5% | 6.4% | -7.8% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.1% |
30.9% |
68.1% |
| SENSEX | 2.9% |
13.9% |
-0.8% |
You may also like the below Video Courses